Legal
Acceptable Use Policy
Last updated Nov 19, 2026
A sequence design tool can be misused. This policy states the limits plainly, so legitimate researchers know where they stand and misuse is not a grey area.
1. Prohibited designs
Any design intended to increase the virulence, transmissibility, host range or immune evasion of a pathogen, or to reconstruct a pathogen that has been eradicated or is controlled.
Any design intended to produce a toxin, toxin subunit or delivery system for a toxin, including sequences whose purpose is to evade synthesis-provider screening.
Any design intended to disable, evade or overwhelm a human immune response outside a declared therapeutic research programme with institutional approval.
Sequences assembled specifically to circumvent the biosecurity screening of a synthesis vendor, including fragmenting a prohibited sequence across orders.
Any use intended to cause harm to people, animals, plants or infrastructure.
2. Screening and enforcement
At submission, inputs and generated candidates get a rule- and keyword-based automatic initial screen against hazard patterns and provider screening conventions. This is an automated first pass, not a guarantee, and it does not replace the screening a synthesis vendor applies before fulfilling an order.
A hit cancels the run before any candidate is produced and the credits are refunded in full. You can submit an appeal at /appeal; appeals are reviewed by a human. Repeated blocks escalate: a warning, then a temporary restriction, then suspension.
A design that falls inside the prohibitions above results in immediate termination and, where we are legally required, a report to the relevant authority.
We cooperate with synthesis providers and with institutional biosafety officers who ask us to confirm what was designed under their account.
3. Research that is allowed
Vaccine antigen design, therapeutic mRNA, siRNA and ASO discovery, CRISPR guide design for research and therapeutic programmes, reporter constructs, enzyme replacement, and standard molecular biology constructs are all permitted.
Work on a controlled pathogen is permitted only with a documented institutional approval reference on the account, and we may ask for it.
Dual-use research that your institution has reviewed and approved is permitted; the approval stays your responsibility to hold.
4. Vendor terms still apply
Order sheets we generate are inputs to a third party. IDT, Twist, GenScript and every other vendor apply their own screening and may refuse an order.
A vendor refusal is not a defect in our output, and it does not entitle you to a refund of design credits.
5. Appeals
If you believe a block was wrong, submit an appeal at /appeal (or from the run page). Appeals are reviewed by a human, usually within two business days.
In an appeal, describe the intended application and attach the institutional approval if one exists.
We will tell you the outcome and, for upheld blocks, which rule applied.
Questions about this document? Write to [email protected]. This page is provided in English; translations are offered for convenience and the English version prevails.